Offer Price Between HK$5.36 and HK$6.96 per Share To Raise Proceeds Up to HK$522 million The Largest Provider of Healthcare Insight Solutions for Medical Products and Channels in China HONG KONG, June 28, 2022 /PRNewswire/ -- A leading healthcare insight solutions provider in China - Sinohealth Holdings Limited ("Sinohealth Holdings" or the "Company", stock code: 2361.HK, together with its subsidiaries, collectively as the "Group"), today announced the proposed listing of its Shares on the Main Board of Hong Kong Exchanges and Clearing Limited ("Hong Kong Stock Exchange"). Sinohealth Holdings plans to offer 75,000,000 Shares (subject to the Over-allotment Option), of which 67,500,000 Shares will be International Placing Shares (subject to reallocation and the Over-allotment Option), representing 90% of the initial Offer Shares; the remaining 7,500,000 Shares will be Hong Kong Offer Shares (subject to reallocation), representing 10% of the initial Offer Shares. Offer Price is between HK$5.36 and HK$6.96 per Share. Sinohealth Holdings will open for Hong Kong Public Offering in Hong Kong at 9 a.m., 28 June 2022 (Tuesday), and close at 12:00 noon, 5 July 2022 (Tuesday). Dealings in Shares of Sinohealth Holdings on the Main Board of the Hong Kong Stock Exchange is expected to commence on 12 July 2022 (Tuesday). The Shares will be traded in board lot of 500 Shares each. The Company's stock code is 2361.HK. BNP Paribas Securities (Asia) Limited is the Sole Sponsor. BNP Paribas Securities (Asia) Limited, CCB International Capital Limited and Orient Securities (Hong Kong) Limited] are the Joint Global Coordinators. BNP Paribas Securities (Asia) Limited, CCB International Capital Limited, Orient Securities (Hong Kong) Limited, Haitong International Securities Company Limited, UOB Kay Hian (Hong Kong) Limited, Guotai Junan Securities (Hong Kong) Limited, Eddid Securities and Futures Limited and Zhongtai International Securities Limited are the the Joint Bookrunners and Joint Lead Managers. Futu Securities International (Hong Kong) Limited, Innovax Securities Limited, Fosun Hani Securities Limited and Livermore Holdings Limited are the Joint Lead Managers. Sinohealth Holdings has a leading position in the medical products and channels segment, mainly providing healthcare insight solutions via offline channels to address the sales and marketing needs of the medical product manufacturer clients. According to the iResearch Report, the Company ranked first for the medical products and channel segment of healthcare insight solutions in the PRC in terms of (i) revenue in 2021, and (ii) number of top medical product manufacturers (based on the lists of top medical product manufacturers in 2020 complied by Torreya and Yaozh.com) and number of corporate clients served in2020. Based on big data and technologies, the Company provides the clients with a value proposition with an emphasis on problem-solving, business growth and evolution of the healthcare industry as a whole. Through a combination of industry knowledge and continuous product development, the Company has developed comprehensive healthcare insight solutions which include customized Data Insight Solutions and Data-driven Publications and Events, and standardized (SaaS) solutions and products for healthcare industry participants under a wide range of application scenarios. The solutions and products help the clients improve their efficiency of operation and management, including their product sales, marketing, client management, supply chain management, research and development, product strategies, strategic decision-making, and corporateinvestment. The Largest Provider of Healthcare Insight Solutions for Medical Products and Channels inChina As one of the first movers of healthcare insight solutions providers, the Company entered the healthcare insight solutions industry in 2008 when it commenced its data collection and data analytics initiatives. As the Company grows its business, its data insights have been widely accepted and are well-received in the healthcare industry. According to the iResearch Report, the Company ranked first in the PRC in terms of revenue generated from healthcare insight solutions for medical products and channels in 2021. Healthcare insight solutions for medical products and channels accounted for approximately 32.9% of the entire healthcare insight solution market in terms of revenue in 2021 and it is expected to increase to 46.9% in 2026. Unlike traditional insight solutions providers, the Company has also invested in the research and development on software products with a view to capture the digital transformation of the healthcare industry. Based on its industry and data insights, the Company has developed a number of SaaS products through continuous product upgrades and technological development. For the years ended 31 December 2019, 2020, and 2021, the SaaS products had 226, 283 and 432 corporate clients, respectively. The Company has developed its own model of product commercialization and monetization. As a result of the efficient, established, and proven business model, the Company has achieved strong profitability. Benefit from Strong Monetization and Focus on Vertically Integrated Solutions that areConsistent with the Unique Characteristics of the Healthcare Industry According to the iResearch Report, high barriers to entry have been established in the healthcare insight solutions industry, making it difficult for new entrants to succeed without investing in a large amount of resources or having a clear profitability model. The Company is competitive as it has been operating in the healthcare insight solutions industry since 2008 and enjoys first-mover advantage. In 2012, the Company began its research and development on commercial big data technologies and established the healthcare databases as well as data standardization systems. With its expertise in the healthcare insight solutions industry and insights into the industry trends, the Company designs the solutions and products that are upgraded and optimized based on its experience and technologies. The Company has created strong brand recognition and has enhanced its industry reputation over the years. The Company mainly provides Data Insight Solutions, Data-driven Publications and Events and a variety of SaaS products that are vertically integrated to the healthcare industry participants. Among them, the Data Insight Solutions cover the main aspects of application scenarios in the healthcare industry, including product sales, marketing, client management, supply chain management, research and development, product strategy, corporate strategies, and investments; the SaaS products are specifically designed to provide a superior and reliable client experience across a wide range of application scenarios for the healthcare industry participant. Enhance the Clients' Business Opportunities through Precision Connection and Marketing,Understand Clients' Needs and Enhance Sales and Marketing Efficiency The Industry Events are the channel for the Company to deliver the Data-driven Publications and Events and generate revenue. The Company provides customized content preparation and review for the clients' publications to deliver to their potential business partners and investors in the promotion of their brands and products during the events. The Company also provides the data insight reports which are tailor-made according to the theme of each event. The content and reports are core values of the events and an important highlight, which has attracted diversified attendees to actively participate in the events for more than adecade. In addition, through the Industry Events, the Company offers valuable opportunities to these industry participants on a regular basis for face-to-face interactions with experts, business partners, peers and clients of the healthcare industry; publications of views and ideas on the industry and corporate strategies; and exhibition, marketing and business exposure. Leveraging the Healthcare Link which keeps track of the activities o